Paper40586641
CALR Type 1-Like Mutations Increase Endoplasmic Reticulum Free Ca2+ and Induce ERK1/2 Activation Independent of Thrombopoietin Receptor Activation.
Faiz M and 2 others. Cell Biol Int, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. CALR Type 1-Like Mutations Increase Endoplasmic Reticulum Free Ca2+ and Induce ERK1/2 Activation Independent of Thrombopoietin Receptor Activation. Papers, record 40586641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40586641
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- CALR Type 1-Like Mutations Increase Endoplasmic Reticulum Free Ca2+ and Induce ERK1/2 Activation Independent of Thrombopoietin Receptor Activation.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Calreticulin | Major topic |
| Endoplasmic Reticulum | Major topic |
| Calcium | Major topic |
| Receptors, Thrombopoietin | Major topic |
| Humans | |
| Mutation | |
| Megakaryocytes | |
| Myeloproliferative Disorders | |
| MAP Kinase Signaling System | |
| Mitogen-Activated Protein Kinase 3 |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| This study was supported by Leukemia & Blood Cancer New Zealand (to Elizabeth C. Ledgerwood). Mifra Faiz was supported by a University of Otago Doctoral Scholarship. | PubMed |
Source PubMed
References68
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36828867 | Clinicohematologic and molecular response of essential thrombocythemia patients treated with pegylated interferon-α: a multi-center study of the German Study Group-Myeloproliferative Neoplasms (GSG-MPN). | Leukemia | 2023 | https://conductscience.org/library/papers/36828867 | PubMed |
| 2 | 17291332 | qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. | Genome Biol | 2007 | https://conductscience.org/library/papers/17291332 | PubMed |
| 3 | 31810292 | The Expression of Myeloproliferative Neoplasm-Associated Calreticulin Variants Depends on the Functionality of ER-Associated Degradation. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31810292 | PubMed |
| 4 | 32823933 | MPN: The Molecular Drivers of Disease Initiation, Progression and Transformation and their Effect on Treatment. | Cells | 2020 | https://conductscience.org/library/papers/32823933 | PubMed |
| 5 | 30528537 | Heterogeneity in myeloproliferative neoplasms: Causes and consequences. | Adv Biol Regul | 2019 | https://conductscience.org/library/papers/30528537 | PubMed |
| 6 | 31697806 | Defective interaction of mutant calreticulin and SOCE in megakaryocytes from patients with myeloproliferative neoplasms. | Blood | 2020 | https://conductscience.org/library/papers/31697806 | PubMed |
| 7 | 26628643 | Rationally engineered Cas9 nucleases with improved specificity. | Science | 2016 | https://conductscience.org/library/papers/26628643 | PubMed |
| 8 | 26668133 | Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants. | Blood | 2016 | https://conductscience.org/library/papers/26668133 | PubMed |
| 9 | 27861742 | Megakaryocytes from CYCS mutation-associated thrombocytopenia release platelets by both proplatelet-dependent and -independent processes. | Br J Haematol | 2017 | https://conductscience.org/library/papers/27861742 | PubMed |
| 10 | 31270458 | Somatic mutations and cell identity linked by Genotyping of Transcriptomes. | Nature | 2019 | https://conductscience.org/library/papers/31270458 | PubMed |
| 11 | 26947070 | Selective Vulnerability of Cancer Cells by Inhibition of Ca(2+) Transfer from Endoplasmic Reticulum to Mitochondria. | Cell Rep | 2016 | https://conductscience.org/library/papers/26947070 | PubMed |
| 12 | 32382708 | Mutant Calreticulin in the Myeloproliferative Neoplasms. | Hemasphere | 2020 | https://conductscience.org/library/papers/32382708 | PubMed |
| 13 | 26697989 | Myeloproliferative neoplasms: Current molecular biology and genetics. | Crit Rev Oncol Hematol | 2016 | https://conductscience.org/library/papers/26697989 | PubMed |
| 14 | 25745188 | The JAK-STAT signaling pathway is differentially activated in CALR-positive compared with JAK2V617F-positive ET patients. | Blood | 2015 | https://conductscience.org/library/papers/25745188 | PubMed |
| 15 | 22373697 | Calreticulin signaling in health and disease. | Int J Biochem Cell Biol | 2012 | https://conductscience.org/library/papers/22373697 | PubMed |
| 16 | 28109427 | Filter-Aided Sample Preparation: The Versatile and Efficient Method for Proteomic Analysis. | Methods Enzymol | 2017 | https://conductscience.org/library/papers/28109427 | PubMed |
| 17 | 36347013 | Genetic basis and molecular profiling in myeloproliferative neoplasms. | Blood | 2023 | https://conductscience.org/library/papers/36347013 | PubMed |
| 18 | 12184808 | Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. | Genome Biol | 2002 | https://conductscience.org/library/papers/12184808 | PubMed |
| 19 | 37424156 | Calreticulin: Endoplasmic reticulum Ca2+ gatekeeper. | J Cell Mol Med | 2024 | https://conductscience.org/library/papers/37424156 | PubMed |
| 20 | 25918716 | Functional roles of calreticulin in cancer biology. | Biomed Res Int | 2015 | https://conductscience.org/library/papers/25918716 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42792882 | The Roles of Genetic and Epigenetic Abnormalities in Essential Thrombocythemia. | Genes (Basel) | 2026 | https://conductscience.org/library/papers/42792882 |
Source PubMed
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CALR | 811 | PubTator's text mining | https://conductscience.org/library/genes/811 | NCBI Gene |
| MPL | 4352 | PubTator's text mining | https://conductscience.org/library/genes/4352 | NCBI Gene |
| PDIA3 | 2923 | PubTator's text mining | https://conductscience.org/library/genes/2923 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40586641
GET https://conductscience.org/api/papers/v1/40586641/references?page=2